The De Boer-van Staveren Fund is intended for innovative basic research on autoimmune diseases by researchers at an early stage of their scientific career
About De Boer-van Staveren Fund to Scientific Researchers on Autoimmune Diseases
Opportunity Details
- Date Published: July 08, 2025
- Application Deadline: July 15, 2025
- Category: Grants
- Oppotunity Locations: Netherlands
The De Boer-van Staveren Fund was established by the Royal Netherlands Academy of Arts & Sciences (KNAW) in 2023 and forms part of the Academy’s Medical Sciences Fund. Its assets consist of the estate of Dr Wilhelmus P.H. de Boer (Haarlem 1950 – Rijswijk 2021). Dr De Boer’s wish was for the KNAW to set up a fund with his estate for medical research, preferably in the field of autoimmune diseases, and to financially support promising, young researchers and new research concepts.
Subject areas
(bio)medical sciences or related disciplines
Benefits of De Boer-van Staveren Fund to Scientific Researchers on Autoimmune Diseases
Each year, a financial contribution of up to € 50,000 can be awarded to three scientific researchers on autoimmune diseases.
De Boer-van Staveren Fund to Scientific Researchers on Autoimmune Diseases Requirements
Scientific researchers
- who conduct basic research in the medical/biomedical sciences or related disciplines;
- who obtained their PhD no more than four (4) years before submitting their application (this term is subject to the Academy's extension arrangement) or are in the final phase of their PhD programme and can start the intended research within three (3) months of being awarded the contribution;
- who will independently set up an innovative research line with the proposed project;
- who will conduct research at a university or research institute in the Kingdom of the Netherlands.
Application Date and Process
Apply Here
Application Deadline
15 July, 2025
Scholarship Application Portal
View details of
De Boer-van Staveren Fund to Scientific Researchers on Autoimmune Diseases
Apply for De Boer-van Staveren Fund to Scientific Researchers on Autoimmune Diseases
